Patient Capital Management’s Expand Energy Corp EXE Stock Holding History

Patient Capital Management’s Portfolio EXE Stock Details EXE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-236,911	Closed	-$23.6M	–	46
2024 Q4	$23.6M	Buy	236,911 +227	+0.1%	+$21K	1.09%	31
2024 Q3	$19.5M	Sell	236,684 -6,553	-3%	-$500K	0.96%	33
2024 Q2	$20M	Sell	243,237 -30,148	-11%	-$2.66M	1.06%	32
2024 Q1	$24.3M	Sell	273,385 -326	-0.1%	-$26.2K	1.18%	35
2023 Q4	$21.1M	Sell	273,711 -45,034	-14%	-$3.7M	1.12%	33
2023 Q3	$27.5M	Sell	318,745 -182,090	-36%	-$15.5M	1.61%	29
2023 Q2	$41.9M	Buy	500,835 +436,335	+676%	+$34.8M	2.33%	24
2023 Q1	$4.9M	Buy	64,500 +26,500	+70%	+$2.18M	2.18%	23
2022 Q4	$3.59M	Buy	38,000 +16,000	+73%	+$1.59M	1.74%	26
2022 Q3	$2.07M	Buy	+22,000	New	+$2.07M	1.03%	36

Other funds holding EXE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

OCM

Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return

Patient Capital Management's EXE Position: Q1 2025 in Review

Patient Capital Management sold out of Expand Energy Corp (EXE) in Q1 2025, closing a stake of 236,911 shares — an estimated $23.6M sold.

Patient Capital Management first reported a position in EXE in Q3 2022 and held it in 10 quarters. The position peaked at $41.9M in Q2 2023. 736 funds tracked by Wall St. Rank hold EXE as of Q1 2025.

Patient Capital Management reported no remaining Expand Energy Corp position as of Q1 2025 after selling out during the quarter.
Patient Capital Management sold 236,911 Expand Energy Corp shares in Q1 2025, an estimated $23.6M.
Patient Capital Management first reported a position in Expand Energy Corp in Q3 2022 and held it in 10 quarters.
Patient Capital Management's Expand Energy Corp position peaked at $41.9M in Q2 2023.
736 funds tracked by Wall St. Rank held Expand Energy Corp as of Q1 2025.

Based on Patient Capital Management's 13F filing for Q1 2025, filed 14 May 2025.